300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Southeast Minnesota Capital Fund, VC Fund

Southeast Minnesota Capital Fund

VC Fund

Rochester, United States

Southeast Minnesota Capital Fund is a VC fund in Rochester focused on Health Care and Medical. SEMN Capital invests in high-growth companies with the potential for high returns. The firm seeks to invest in the healthcare sector and founders. It was established in 2017 and is headquartered in Rochester, Minnesota.

Total investments:
10
Last investment:
Lead investor:
0%

Last updated:

Industries Southeast Minnesota Capital Fund invests in

Health CareMedicalMedical DeviceHealth DiagnosticsShopping

Stages Southeast Minnesota Capital Fund invests in

SeedPre-SeedSeries ASeries B

Countries Southeast Minnesota Capital Fund invests in

United States

Round sizes

Seed $100k–$2.1M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$100k–$2.1M

Investment Focus

Industry

  • Health Care 4 (40%)
  • Medical 2 (20%)
  • Medical Device 2 (20%)
  • Health Diagnostics 2 (20%)
  • Shopping 1 (10%)
See all 13 industries →

Stage

  • Seed 6 (60%)
  • Pre-Seed 1 (10%)
  • Series A 1 (10%)
  • Series B 1 (10%)

Team

NameTitleInvestmentsLinksEmail
Xavier Frigola
Xavier Frigola Treasurer
Treasurer Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Melodi Melodi
Melodi Health provides innovative technologies that improve patient outcomes and lower healthcare costs for women undergoing breast surgery. $10.8M / Series A / Aug 29, 2024
Vyriad Vyriad
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. $29.5M / Series B / May 17, 2022
Omnia Fishing Omnia Fishing
Omnia Fishing is an eCommerce store that allows anglers to find, buy, and organize their fishing gear based on the bodies of water they fish with a "shop-by-lake" concept. Anglers rely on information specific to their water body, species, styles, season, and others. $2.1M / Seed / Feb 18, 2021
Omnia Fishing Omnia Fishing
Omnia Fishing is an eCommerce store that allows anglers to find, buy, and organize their fishing gear based on the bodies of water they fish with a "shop-by-lake" concept. Anglers rely on information specific to their water body, species, styles, season, and others. $1.2M / Seed / May 05, 2020
Marani Marani
Marani Health is a leading maternal healthcare technology company dedicated to transforming prenatal and postpartum care through AI-powered remote monitoring solutions. Our flagship platform, M•care System, connects expectant mothers with qualified healthcare professionals through advanced digital health technology, ensuring comprehensive carethroughout pregnancy. Serving health plans, maternity providers, employers, and patients, Marani's solutions enhance clinical workflows, reduce unnecessary interventions, and improve maternal and fetal outcomes. Marani Health is committed to improving maternal and fetal health outcomes while addressing healthcare access disparities in all communities.At Marani Health, we envision a world where every pregnancy is supported by personalized, proactive, and equitable care—empowering mothers and care teams with the tools and insights needed to ensure healthier beginnings for all. $1.5M / Seed / Aug 12, 2019
Endogenex Endogenex
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D. $100K / Pre-Seed / Nov 01, 2018
Endogenex Endogenex
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D. $100K / Seed / Nov 01, 2018
Sonex Health Sonex Health
ABOUT SONEX HEALTH “Refined simplicity” is the guiding principle behind Sonex Health, LLC, to drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians Darryl Barnes, MD and Jay Smith, MD and business operations expert Aaron Keenan founded Sonex Health in2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.ABOUT THE SX-One MicroKnife The ultra-low profile SX-One MicroKnife with Meerkat Technology™ is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives. $500K / Seed / Aug 21, 2018
Vyriad Vyriad
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. $500K / Seed / Aug 21, 2018
Oculogica Oculogica
Oculogica is a medical device manufacturing company that specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye-tracking. The company's EyeBOX device is the only baseline-free test authorized by the FDA as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI). It requires nobaseline data nor individual calibration, and therefore results cannot be influenced by patient will.Oculogica was established in 2013 and is based in New York, NY, United States. $1.2M / Seed / May 01, 2016

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Southeast Minnesota Capital Fund invest in?

Southeast Minnesota Capital Fund invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Southeast Minnesota Capital Fund's check size?

Southeast Minnesota Capital Fund typically joins rounds of $100k–$2.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Southeast Minnesota Capital Fund participates in.

How do I contact Southeast Minnesota Capital Fund?

Public channels for Southeast Minnesota Capital Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Southeast Minnesota Capital Fund?

The team at Southeast Minnesota Capital Fund includes Xavier Frigola (Treasurer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Southeast Minnesota Capital Fund Southeast Minnesota Capital Fund Find emails